Barclays Lowers Laboratory Co. of America (NYSE:LH) Price Ta

Laboratory Co. of America (NYSE:LH – Get Free Report) had its price target cut by analysts at Barclays from $234.00 to $213.00 in a research report issued on Friday, Benzinga reports. The brokerage currently has an “equal weight” rating on the medical research company’s stock. Barclays‘s price objective would indicate a potential upside of 7.36% […]

Related Keywords

United States , America , Leerink Partnrs , Robertw Baird , Marks Schroeder , Vaart Sandrad Van , Laboratory Corporation Of America Holdings , News Ratings For Laboratory Co , Provence Wealth Management Group , Tradewinds Capital Management , Exchange Traded Concepts , Analyst Recommendations For Laboratory Co , America Company Profile , Laboratory Co , Biopharma Laboratory Services , Barclays , Insider Transactions At Laboratory Co , Bruceg Allen Investments , Mendota Financial Group , Securities Exchange Commission , Get Free Report , Vaart Sandra , Exchange Commission , Wealth Management Group , Financial Group , Capital Management , Traded Concepts , America Company , America Holdings , Labcorp Diagnostics , America Daily , Laboratory Co Of America , Nyse Lh , Lh , Medical , 50540r40 , Lower Price Target , Barclays Plc ,